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INTRODUCTION
C. difficile-associated diarrhea (CDAD), the most
frequently identified cause of nosocomial diarrhea[1], results
from the overgrowth of cytotoxin (toxin B)-producing strains.
Toxigenic culture of C. difficile is considered to be the most
sensitive test for diagnosis of the disease[2], but it is not
highly specific as some non-infected persons[3] and many
hospitalized patients carry both toxigenic and non-toxigenic
C. difficile in their intestine. The use of vancomycin to treat
CDAD is considered to be one of significant factors to
increase in vancomycin-resistant enterococci[4, 5]. More
specific methods for the diagnosis of CDAD may reduce the
use of vancomycin and, consequently, the emergence of
vancomycin-resistant enterococci[6, 7]. 
Quantitative and semi-quantitative cultures are used in
routine diagnostic microbiology, to improve the specificity
of the results, in such specimens as expectorated sputum and
voided urine, which inevitably contain contaminated
potential pathogens[8]. The use of a quantitative method is
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also recommended for the culture of C. difficile from fecal
specimens[9], but its clinical significance is not known. The
aim of this study was to evaluate whether the quantitative
culture of C. difficile can improve the specificity of the
results. 
MATERIALS AND METHODS
Loose stool specimens were obtained in the period from
1997 to 1999 from inpatients suspected of having CDAD,
either pseudomembranous colitis (PMC) or antibiotic-
associated diarrhea (AAD). A 0.1-mL amount of a serial 10-
fold dilution of the specimens in a thioglycollate medium
without dextrose or indicator (Becton Dickinson,
Cockeysville, Md., USA) was spread onto a prereduced,
amphotericin B-supplemented CCFA plate[10]. After 48-h
incubation in an anaerobic chamber (Forma Scientific,
Marrieta, OH, USA), suspected C. difficile colonies were
counted and identified using the ATB 32A system
(bioMerieux sa, Marcy-l’Etoile, France). The number of
colonies was expressed per mL of original stool specimen.
The detection limit of C. difficile in this study was 102
CFU/mL. 
Cytotoxin gene of the isolate was detected by PCR, which
was performed using the Mastercycler gradient (Eppendorf,
Hamburg, Germany), with 1 μL each of oligonucleotide
primers, designed by Gumerlock et al.[11], 1 μL of heat
extracted template, AccuPower PCR PreMix (Bioneer Co.,
Daejeon, Korea) containing 1 U of Taq DNA polymerase.
The reaction conditions were: 35 cycles of denaturation at 93
℃ for 30 seconds, annealing at 58℃ for 30 seconds, and
extension at 72℃ for 30 seconds. 
Colonoscopy and histologic examination of the biopsy
specimens were also performed in 97 suspected CDAD
patients, and for these patients, the colonoscopic and
histologic findings were compared to the culture results,
retrospectively. 
RESULTS
The culture of 2,701 specimens yielded 495 (18.3%)
unduplicated isolates of C. difficile, and of these, 402
(81.2%) were cytotoxin-gene positive (Table. 1). The count
of both cytotoxin gene-negative and -positive isolates was in
the range 102-≥106 CFU/mL. However, among the
cytotoxin-positive isolates, 3.2% contained 102-<104
CFU/mL, while 74.9% contained ≥106 CFU/mL. Among
the cytotoxin-negative isolates, 8.6% contained 102-<104
CFU/mL, while 50.5% contained ≥106 CFU/mL. The
proportion of cytotoxin gene-positive isolates was higher in
the specimens with ≥106 CFU/mL of C. difficile than in
those with 102-<103 CFU/mL (86.5% vs. 66.7%) (Fig. 1). 
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Table 1. Results of C. difficile quantitative culture of fecal specimen from CDAD-suspected patient by cytotoxin gene-positive
and-negative strains
No. (%) of specimens with C. difficile (CFU/mL)
102-<103 103-<104 104-<105 105-<106 ≥106
Positive 4 (1.0) 9 (2.2) 30 (7.5) 58 (14.4) 301 (74.9) 402 (100)
Negative 2 (2.1) 6 (6.5) 16 (17.2) 22 (23.7) 47 (50.5) 93 (100)
Total 6 (1.2) 15 (3.0) 46 (9.3) 80 (16.2) 348 (70.3) 495 (100)
Cytotoxin gene Total
Table 2. Isolation frequency of cytotoxin gene-positive and-negative strains of C. difficile from stool specimens according to
the patients’diagnosis
(No. of patients) C. difficile (CFU/mL):
Cytotoxin gene(+) Cytotoxin gene(-) No growth
104-105 ≥106 104-105 ≥106 (<102)
Pseudomembranous colitis (15) 12 9 0 0 52
Colitis (60) 1 4 1 2 52
No abnormal finding (22) 2 4 0 1 15
Total (97) 4 17 1 3 72
* By colonoscopy/histologic findings. 
Diagnosis *
(No. of patients)
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Among the 97 patients who were examined by
colonoscopy and/or histology of biopsy specimens, 15 were
diagnosed as having PMC and 60 had findings of colitis, but
for the remaining 22, no abnormalities were found (Table 2).
Among the specimens from the 15 patients diagnosed as
having PMC, 10 yielded cytotoxin gene-positive C. difficile:
one with 104 CFU/mL, and 9 with ≥106 CFU/mL. C.
difficile was not isolated from the specimens of the
remaining 5 PMC patients. 
Among the specimens from the 60 patients with findings
of colitis, the numbers of specimens which yielded 104
CFU/mL and ≥106 CFU/mL of cytotoxin gene-positive
isolates were only 1 and 4, respectively. Three (5%) patients
yielded cytotoxin gene-negative isolates and the remaining
52 (86.7%) were negative for C. difficile culture. In the 22
patients with no abnormal colonoscopic or histologic
findings, 2 (9.1%) and 4 (18.2%) yielded 104-105 CFU/mL
and ≥106 CFU/mL of cytotoxin gene-positive isolates,
respectively. 
DISCUSSION
C. difficile, a major cause of AAD and PMC, is the most
frequently identified cause of hospital-acquired diarrhea.
CDAD can be treated with oral vancomycin, metronidazole
or antibiotics withdrawal[12]. There is some controversies
about which detection method is optimal for the diagnosis of
CDAD[13]. In regards with the bacteriological method, the
culture has been a mainstay in the laboratory diagnosis of
CDAD and is essential for the epidemiologic study of
nosocomial isolates[14]. 
However, the culture alone often leads to misdiagnosis of
CDAD, because normal adults may carry C. difficile in their
intestine, but, in this case, their number was reported to be
only ≤102 CFU/mL[3]. It is well recognized that both PMC
and many cases of AAD are due to an overgrowth of
cytotoxin-producing C. difficile[2], but an evaluation based
on quantitative studies are not known. In this study, it was
shown that the number of cytotoxin gene-positive C. difficile
in 99% of the stool of suspected CDAD patients was ≥103
CFU/mL (Table 1). In fact, 89.3% of the samples had a count
of ≥105 CFU/mL. This result supports the notion that an
enrichment culture is not necessary for the diagnosis of
CDAD. In fact, an enrichment culture may detect
asymptomatic carriers, resulting in potentially misleading
indications to unnecessary vancomycin therapy. 
In our study, the quantitative culture showed some merit to
distinguish patients with toxigenic strains from those with
nontoxigenic ones (Fig. 1). It may be natural that nontoxigenic
isolates can also attain high numbers when there is
antimicrobial pressure, as their antibiotic resistance may not be
different from that of the toxigenic strains. 
C. difficile infection may be associated with a wide
spectrum of severity, ranging from mild diarrhea, through
severe disease with watery diarrhea, to sometimes fatal
PMC[15]. Colonoscopic findings are highly specific, but not
sensitive enough for the diagnosis of PMC, because the
lesion may be difficult to find in some patients, depending on
the site and extent of the lesion[16]. Histological
examination also has some limitations, because the biopsy
specimens cannot be taken from appropriate site and the
findings, in the case of mild CDAD, are not specific[17].
Therefore, diagnosis of CDAD is generally based both on
clinical findings and on the presence of cytotoxin-producing
C. difficile in the stool[18]. 
Hence, it may seem illogical to evaluate the results of the
C. difficile culture based on the findings of colonoscopy and
histologic examination. However, the reason of comparing
the two findings in this study was to determine any
difference in the positive rate and number of C. difficile. It
was reported that the stool of patients with PMC contained
107 CFU/mL or more of C. difficile[2]. In this study, the
number of cytotoxin gene-positive C. difficile in the stool of
PMC patients was also high, ≥106 CFU/mL. One specimen,
which yielded only 104 CFU/mL of C. difficile, and another
sample which did not yield any C. difficile growth, were
taken from two PMC patients after the initiation of anti-C.
difficile treatment. This implies that prior treatment might
suppress the growth of C. difficile, partially or completely.
Specimen collection, before initiation of antimicrobial
therapy, is important in the culture of C. difficile, as it is in
the case of other bacterial cultures. 
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Fig. 1. Proportion of cytotoxin-positive C. difficile by
number of the organisms in the stool specimen.
It was surprising that the specimens of 5 of the 15 patients
in this study, who were diagnosed as having PMC by
colonoscopy or microscopy, did not yield C. difficile,
considering that the organism is associated with 90-100% of
cases of PMC[1]. The specimens did not yield growth of
Salmonella and Shigella spp. Although the possibility may
be low, other infectious organisms, such as C. perfringens,
Staphylococcus aureus, Klebsiella oxytoca, or Candida
species, which have not been examined, may have caused the
intestinal lesion[19]. 
Among the 60 patients who were initially suspected of
having CDAD and subsequently categorized as having
colitis, based on colonoscopy and histology, only 5 patients
yielded cytotoxin gene-positive C. difficile. The fact that the
vast majority of the suspected CDAD patients did not have
the disease indicates the importance of toxigenic culture for
the diagnosis of CDAD[17]. It is known that only 10%-20%
of all cases of AAD are caused by C. difficile and most of the
clinically mild AAD cases are due to functional disturbances
of intestinal carbohydrate or bile acid metabolism, to the
allergic and toxic effects of antibiotics on intestinal mucosa,
or to the pharmacological effects on motility[20]. 
In light of this study, the presence of the organism in very
large numbers may represent a useful factor in the
interpretation of the culture results. We suggest that the
number of C. difficile be reported quantitatively by CFU/mL
or, at least semi-quantitatively, when a quantitative culture
was not performed[9].
The absence of cytotoxin gene-positive C. difficile in
many specimens collected from suspected CDAD patients
indicates the importance of using a culture method, in order
to reduce unnecessary therapy. The detection of a high
number of cytotoxin gene-positive C. difficile by quantitative




환자 설사의 가장 흔한 원인이며 , cytotoxin 생성 C.
difficile에 의해 발생한다. 본 연구에서는 CDAD 진단을
위한 C. difficile 정량배양의 유용성을 평가하고자 하였
다. 
방배법：대장내시경과 조직생검 소견을 기준으로 C.
difficile cytotoxin 유전자와 정량배양결과를 비교 평가하
였다. 
결배과：Cytotoxin 양성 402 검체 중 301 (74.9%) 검체
에서 분리된 C. difficile 균수는 106 CFU/mL 이상이었고,
위막성 대장염 환자 15명중 9명(60%)의 검체에서는
cytotoxin 양성 균수가 106 CFU/mL 이상이었다 .
Cytotoxin 양성 균주의 비율은 C. difficile 수가102-103
CFU/mL인 검체에서는 66.7%이었고, 106 CFU/mL이상인
검체에서는 86.5%로더높았다. 
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